Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enlight Medical has developed the NovoClasp® transcatheter mitral valve repair system, which has completed its first-in-human implant. The company’s thoracic endovascular stent graft for aortic dissection is commercially available in China. Several innovative products are in clinical trials or have been submitted for regulatory review. Their BCI/neurotechnology pipeline includes invasive/non-invasive devices approaching animal studies or early human trials
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enlight Medical.